Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Prostate Cancer / April 2007

Tip: Looking for answers? Try searching our database.

Seeds vs. RP Study

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Tom Cular - 07 Apr 2007 11:25 GMT
The following is a link to a Medscape article comparing RP and Seed
implants.

http://www.medscape.com/viewarticle/554769

Tom
chasjac - 07 Apr 2007 17:09 GMT
Thanks for posting that, Tom.

I had two thoughts after reading it:

1.  I wonder if they broke down the radical prostatectomy (RP) group
into retropubic (RRP) and laparoscopic (LRP).  One of the arguments in
favor of LRP is that the recovery time is shorter, which might be a
factor to think about in the societal cost component of the study.

2.  I also wonder if a missing ingredients in the quality of life
(QOL) evaluations is something like a performance gap measure.  This
is central feature of a couple of the test instruments used in
educational institution research.  Students are typically asked not
only how they rate a particular aspect of their college or university,
but also how important that aspect is to them.  If they have low
expectations about something -- say dorm food quality -- then it
matters less to the college if they rate that lower.  On the other
hand, if it's important to them and they rate it low, then the college
ought to address it.
Do QOL studies about prostate cancer include questions that address
this sort of thing?  I know I filled out a couple of surveys at Johns
Hopkins, but I don't recall questions that I'd recognize as addressing
performance gap -- though I admit I was still overwhelmed by the PCa
diagnosis at the time.   I would think that the performance gap
profile might be considerably different for men in the RP group than
for those in the seeds group.

--charlie
I.P. Freely - 07 Apr 2007 17:57 GMT
> Do QOL studies about prostate cancer include questions that address
> this sort of thing?  

When I was wallowing in highly motivated literature research on initial
and adjuvant treatments a couple of years ago, one thing not only stood
out to me but was explicitly lamented in some of the studies: PC
treatment studies very often gloss over -- some ignore altogether --
SEs, especially in ADT studies where SEs are a major factor (some
experts say THE factor) in choosing which ADT regimen or whether to
undertake ADT at all. And even if the studies are heeding those
complaints and beginning to recognize that SEs not only matter but are
often deal-breakers, the problem often surfaces right here that doctors
are paying little attention to SE education or impact. Given that, and I
 believe it is a given, I doubt the next step, the performance gap, is
high on researchers' priorities yet.

I'd love to see that paragraph shot down, because some day I may have to
start digging into salvage/adjuvant tx literature again, and very much
want to include SES. Right now I'm enjoying and heeding my oncs' strong
advice to get on with my real life and quit wallowing in literature
until my PSA comes roaring back and/or some new tx is proven to
cure/prevent PC or its return. i.e., he advises that my PC research be a
necessary means to a specific end, not an obsession with a life of its own.

I.P.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.